A chemistry analysis conducted by Jellagen Pty Ltd into the functionalisation of collagen and its fabrication into novel wound healing devices targeting diabetic foot ulcers.

杰拉根有限公司（JPL）的目标是进行一个概念验证研究项目，研究胶原蛋白的功能化及其在新型伤口愈合装置中的制造。该项目旨在评估将功能化胶原蛋白纳入伤口愈合装置的潜力，用于一系列应用，包括糖尿病足溃疡（DFU）的治疗。这种新颖的伤口愈合装置旨在取代现有的DFU和其他伤口愈合应用技术，作为一种更有效、更容易使用和更容易获得的治疗选择。这个装置将由我们的新型水母胶原蛋白制成。水母胶原蛋白是一种高度生物相容性的生物材料，与现有的哺乳动物来源的胶原蛋白相比，它已经显示出更高的功效和性能，因此它是构建伤口愈合装置的理想材料。这意味着成品设备有可能彻底改变DFU的治疗，减少医疗服务的经济压力，改善DFU患者的治疗和生活质量。

Jellagen Pty Ltd (JPL) aims to conduct a Proof of Concept research project into thefunctionalisation of collagen and its fabrication into novel wound healing devices. The projectaims to evaluate the potential of incorporating functionalised collagen into wound healingdevices for a range of applications including the treatment of diabetic foot ulcers (DFU). Thisnovel wound healing device is designed to replace existing technologies for DFU and otherwound healing applications, as a more effective, easier to use and more accessible treatmentoption. The device will be constructed from our novel jellyfish collagen. Jellyfish collagen isa highly biocompatible biomaterial that has shown improved efficacy and performance overexisting mammalian sourced collagen, and as a result it is an ideal material from which toconstruct wound healing devices. This means that the finished device has the potential torevolutionise the treatment of DFU, reducing economic pressure on health services andimproving the treatment of and quality of life for sufferers of DFU.